Role of p38 and p44/42 mitogen‐activated protein kinases in microglia
- 4 October 2002
- Vol. 40 (2) , 175-183
- https://doi.org/10.1002/glia.10151
Abstract
Although microglial cells are thought to play a beneficial role in the regeneration and plasticity of the central nervous system (CNS), recent studies have indicated that at least some molecules released by microglia may be harmful in acute brain insults and neurodegenerative diseases. Therefore, the pathways mediating the synthesis and release of these neurotoxic compounds are of importance. p38 and p44/42 families of mitogen‐activated protein kinases (MAPKs) in microglia respond strongly to various extracellular stimuli, such as ATP, thrombin, and β‐amyloid, a peptide thought to be responsible for the neuropathology in Alzheimer's disease. In this review we describe in vivo evidence implicating that p38 and p44/42 MAPKs may play a critical role in harmful microglial activation in acute brain injury, such as stroke, and in more chronic neurodegenerative diseases, such as Alzheimer's disease. We also clarify the extracellular signals responsible for activation of p38 and p44/42 MAPK in microglia and review the responses so far reported to be mediated by these kinases. GLIA 40:175–183, 2002.Keywords
This publication has 109 references indexed in Scilit:
- Participation of protease‐activated receptor‐1 in thrombin‐induced microglial activationJournal of Neurochemistry, 2002
- p38-dependent marking of inflammatory genes for increased NF-κB recruitmentNature Immunology, 2001
- CD45 Inhibits CD40L-induced Microglial Activation via Negative Regulation of the Src/p44/42 MAPK PathwayPublished by Elsevier ,2000
- Regulation of Interleukin-1 -Induced Interleukin-6 Gene Expression in Human Fibroblast-Like Synoviocytes by GlucocorticoidsThe Journal of Biochemistry, 1998
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997
- Molecular Mechanism of Alzheimer's Neurofibrillary Degeneration and Therapeutic InterventionaAnnals of the New York Academy of Sciences, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Transgenic mouse brain histopathology resembles early Alzheimer's diseaseAnnals of Neurology, 1994
- The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domainCell, 1993
- Alzheimer's Disease Neuropathology: Current Status of Interpretation of Lesion DevelopmentaAnnals of the New York Academy of Sciences, 1992